Nalu Medical

Nalu Medical is a California-based medical technology company that develops innovative and minimally invasive solutions for patients with chronic neuropathic pain. The company's key product offering is the Nalu Neurostimulation System, which delivers gentle electrical pulses to the nervous system to modulate pain signals before they reach the brain.

The Nalu Neurostimulation System consists of a fully featured, battery-free, miniaturized implantable pulse generator (IPG) called the micro-IPG. It is powered wirelessly by an externally worn Therapy Disc and controlled through a smartphone-based remote-control app. The micro-IPG delivers treatment capabilities similar to larger IPGs, with unique advantages associated with advanced waveforms, extensive programming options, exceptional upgradability, and an expected service life of 18 years.

The Nalu System was designed to address major unmet needs in the treatment of chronic neuropathic pain and provide a differentiated value proposition for patients and physicians. It has been approved by the US FDA for Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) indications.

The company focuses on developing and commercializing advanced minimally invasive solutions for patients with chronic neuropathic pain. Its Neurostimulation System is designed to deliver gentle electrical pulses to the nervous system to modulate pain signals to the brain. As of January 2024, Nalu had raised USD 65 million in funding from Novo Holdings to accelerate commercial growth, expand clinical and health-economic evidence, continue product development, and scale operations.

Key customers and partnerships

Based on the information provided, there are no specific details about Nalu Medical's key customers or partnerships. However, the company states that it continues to invest in building clinical data to expand access for patients who often don't have other therapeutic options.